1077FF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...
ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...
The purpose of this study is to determine whether one or two four-month regimens of tuberculosis treatment are as effective as a...
A5361s is a prospective study to determine the effects of pitavastatin on physical function. The study will enroll participants...
Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...
